Oramed Pharmaceuticals Inc. (ORMP)

NCM – Real Time Price. Currency in USD

4.27

+0.02 (0.47%)

Market open: Aug 12, 2026, 12:21 PM EDT

4.25

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 4:10 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-2M

-193K

Gross Profit

13K

-193K

Operating expenses (excl. COGS)

-15M

-13M

-17M

-43M

Operating Income

-15M

-13M

-16M

-41M

Non-operating income, total

90M

-3M

21M

Pretax income

75M

-16M

-38M

Equity in earnings

Taxes

-11M

-3M

-100K

Non-controlling/minority interest

34K

43K

437K

After tax other income/expense

-808K

Net income before discontinued operations

63M

-19M

-37M

Discontinued operations

Net income

63M

-19M

-37M

Dilution adjustment

359K

Preferred dividends

Oramed Pharmaceuticals Inc. (ORMP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Oramed Pharmaceuticals Inc. (ORMP)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Oramed Pharmaceuticals Inc. (ORMP)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Oramed Pharmaceuticals Inc. (ORMP)

Income Statement (Annual)

Income Statement (Annual)